Club Jules Gonin 2026

Earlier treatment yields better outcomes: 5-years of pegcetacoplan treatment for geographic atrophy secondary to AMD
Access Resources

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

The safety and efficacy of the agents under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available fo rthe uses being investigated.